Literature DB >> 23026624

Tricuspid valve injury after heart transplantation due to endomyocardial biopsy: an analysis of 3550 biopsies.

A I Fiorelli1, G H B Coelho, V D Aiello, L A Benvenuti, J F Palazzo, V P Santos Júnior, B Canizares, R R Dias, N A G Stolf.   

Abstract

INTRODUCTION: Tricuspid regurgitation (TR) is the most commonly valvular dysfunction found after heart transplantation (HTx). It may be related to endomyocardial biopsy (EMB) performed for allograft rejection surveillance.
OBJECTIVE: This investigation evaluated the presence of tricuspid valve tissue fragments obtained during routine EMB performed after HTx and its possible effect on short-term and long-term hemodynamic status.
METHOD: This single-center review included prospectively collected and retrospectively analyzed data. From 1985 to 2010, 417 patients underwent 3550 EMB after HTx. All myocardial specimens were reviewed to identify the presence of tricuspid valve tissue by 2 observers initially and in doubtful cases by a third observer. The echocardiographic and hemodynamic parameters were only considered for valvular functional damage analysis in cases of tricuspid tissue inadvertently removed during EMB.
RESULTS: The 417 HTx patients to 3550 EMB, including 17,550 myocardial specimens. Tricuspid valve tissue was observed in 12 (2.9%) patients corresponding to 0.07% of the removed fragments. The echocardiographic and hemodynamic parameters of these patients before versus after the biopsy showed increased TR in 2 cases (2/12; 16.7%) quantified as moderate without progression in the long term. Only the right atrial pressure showed a significant increase (P = .0420) after tricuspid injury; however, the worsening of the functional class was not significant enough in any of the subjects. Thus, surgical intervention was not required.
CONCLUSIONS: Histological evidence of chordal tissue in EMB specimens is a real-world problem of relatively low frequency. Traumatic tricuspid valve injury due to EMB rarely leads to severe valvular regurgitation; only a minority of patients develop significant clinical symptoms. Hemodynamic and echocardiographic alterations are also less often observed in most patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23026624     DOI: 10.1016/j.transproceed.2012.07.024

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Magnetic resonance imaging of the transplanted pediatric heart as a potential predictor of rejection.

Authors:  Steven C Greenway; Frederic Dallaire; Paul F Kantor; Anne I Dipchand; Rajiv R Chaturvedi; Monali Warade; Eugenie Riesenkampff; Shi-Joon Yoo; Lars Grosse-Wortmann
Journal:  World J Transplant       Date:  2016-12-24

2.  Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.

Authors:  Ludwig T Weckbach; Ulrich Maurer; Rene Schramm; Bruno C Huber; Korbinian Lackermair; Max Weiss; Bruno Meiser; Christian Hagl; Steffen Massberg; Sandra Eifert; Ulrich Grabmaier
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

3.  Accidental Entrapment of Electrical Mapping Catheter by Chiari's Network in Right Atrium during Catheter Ablation Procedure.

Authors:  Atsushi Sakamoto; Tsuyoshi Urushida; Tomoaki Sakakibara; Makoto Sano; Kenichiro Suwa; Takeji Saitoh; Masao Saotome; Hideki Katoh; Hiroshi Satoh; Hideharu Hayashi
Journal:  Case Rep Cardiol       Date:  2016-06-05

4.  Platypnea-Orthodeoxia Syndrome Associated with Spontaneously Ruptured Chordae Tendineae of Tricuspid Valve.

Authors:  Motoki Uchihashi; Masahiro Makino; Satoshi Kaimoto; Yuta Imai; Mitsuyoshi Hadase; Hiroyuki Kurata; Takashi Nakamura
Journal:  CASE (Phila)       Date:  2019-11-15

Review 5.  A Meta-Analysis on Prophylactic Donor Heart Tricuspid Annuloplasty in Orthotopic Heart Transplantation: High Hopes from a Small Intervention.

Authors:  Alberto Emanuel Bacusca; Andrei Tarus; Alexandru Burlacu; Mihail Enache; Grigore Tinica
Journal:  Healthcare (Basel)       Date:  2021-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.